drugset / Trial / NCT00890591
Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension
NaSingle-groupOpen-labelTreatment
Summary
In patients naive to treatment or after a 2-week washout period for patients whose treatment was ineffective, the use of olmesartan was assessed in a 4-phase treatment scheme: monotherapy, addition of hydrochlorothiazide (2 phases), addition of amlodipine.
Timeline
- Start
- 2006-08
- Primary completion
- 2007-06
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | — | — |
| Subject | Hydrochlorothiazide | Unknown | — | — |
| Subject | Olmesartan medoxomil | Unknown | — | — |